Q1 2022 Vitrolife AB Earnings Call Transcript
Good day, and thank you for standing by. Welcome to the interim report January to March 2022. (Operator Instructions) I must advise you that today's conference is being recorded. I would now like to hand the conference over to our speaker today, Mr. Thomas Axelsson. Thank you, and please go ahead.
()-&
Thank you very much, and welcome to Vitrolife Interim Report January-March 2022. The speakers of today will be the CFO of the company, Patrik Tolf; and myself, Thomas Axelsson, and I am the CEO of the company. Please go to Page #2, so we can look through this report.
This is the first quarter that we have done within the Vitrolife group, the combination of the service business within the genetic field and the device business from, let's say, the earlier Vitrolife. What we are doing and the ambition between this group is to continue to have good, good growth, and a good momentum is what we can see in this quarter.
We will go through in this
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investorsā 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |